Log In
BCIQ
Print this Print this
 

finasteride (P-3074)

  Manage Alerts
Collapse Summary General Information
Company Almirall S.A.
Description0.25% finasteride cutaneous solution
Molecular Target 5-alpha reductase
Mechanism of Action5-alpha reductase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationAlopecia
Indication DetailsTreat androgenetic alopecia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today